The bill proposes the addition of a new section, 376.389, to chapter 376 of the Revised Statutes of Missouri, which focuses on insurance coverage for prescription insulin drugs. It establishes definitions for key terms such as "cost-sharing," "enrollee," "health benefit plan," and "prescription insulin drug." The bill mandates that health benefit plans providing coverage for prescription insulin drugs cannot impose cost-sharing that exceeds thirty dollars for a thirty-day supply. Furthermore, it requires that the cost-sharing for these drugs be calculated at the point of sale based on a price reduced by the total amount of rebates received by the health carrier. Additionally, the bill includes provisions to protect the confidentiality of rebate information, stating that health carriers are not required to disclose specific rebate amounts, which are considered trade secrets. It also clarifies that the section will apply to health benefit plans that are delivered, issued for delivery, continued, or renewed on or after January 1, 2027. If any part of this section is deemed invalid, the remaining provisions will still be enforceable.

Statutes affected:
Introduced (6910H.01): 376.389